Sinus Dilation Devices Market (By Product: Balloon Sinus Dilation Devices, Endoscopes, Sinus Stents/Implants, Functional Endoscopic Sinus Surgery (FESS) Instruments Set, Others; By Type: Sinuscopes, Rhinoscopes; By Procedure: Standalone, Hybrid; By Patient: Adult, Pediatric; By End-use: Hospitals, Ambulatory Surgical Centers, Ent Clinics/in Office) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global sinus dilation devices market size was valued at USD 3.02 billion in 2023 and is anticipated to reach around USD 7.60 billion by 2033, growing at a CAGR of 9.67% from 2024 to 2033. The production of balloon sinuplasty, image-guided surgery, drug-eluting stents, advanced endoscopic tools, biologics, targeted therapies, cryotherapy, 3D printing, AI, and machine learning technical advancement in sinus treatment can be the opportunity to boost the sinus dilation devices market.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. sinus dilation devices market size was estimated at USD 950 million in 2023 and is predicted to be worth around USD 2,440 million by 2033 with a CAGR of 9.89% from 2024 to 2033.
North America dominated the sinus dilation devices market in 2023. North America boasts a highly developed healthcare infrastructure with state-of-the-art facilities, cutting-edge medical technology, and highly qualified healthcare staff, especially in the United States and Canada. The widespread acceptance and application of sinus dilation devices are facilitated by this infrastructure. Because of the region's prominence as a center for medical device invention and research, state-of-the-art sinus dilation devices with enhanced patient outcomes, safety, and efficacy have been developed.
The development of cutting-edge technology propels market supremacy and expansion. Chronic sinusitis and nasal polyps are two common sinus-related conditions in North America brought on by lifestyle choices, allergies, and pollutants. The need for sinus dilation techniques and devices is increased by the growing occurrence of these disorders. In the region, people are encouraged to pursue medical treatments, such as sinus dilation operations, by means of extensive health insurance coverage and advantageous reimbursement systems. This funding encourages market domination and expansion.
Asia Pacific is expected to host the fastest-growing sinus dilation devices market over the forecast period. In the area, chronic sinusitis is becoming more common due to factors like rising pollution, urbanization, and changing lifestyles. There is an increasing need for efficient treatment options, such as sinus dilation devices, due to this expanding patient population. Asia Pacific has many nations making significant investments in their healthcare system. This involves implementing cutting-edge medical technology and growing healthcare facilities, which make sinus dilation devices more accessible and easier to use.
The sinus dilation devices market refers to medical devices used to treat chronic sinusitis, a condition determined by swelling and inflammation of sinus linings that causes breathing difficulties, blocked nasal passages, and other related symptoms. By increasing the number of sinus openings, these devices can improve ventilation and drainage, alleviate symptoms of sinus infection, and lower the incidence of sinus infection.
The balloon sinuplasty is the most often carried out procedure with sinus dilation devices. The small, flexible balloon catheter is inserted into the sinus passage during this minimally invasive procedure. After that, the balloon is gradually inflated to widen the sinus aperture. The balloon is deflated and removed after widening the passage, expanding the sinus cavity, and enhancing drainage and airflow.
The sinus dilation devices market is fragmented with multiple small-scale and large-scale players, such as Smith+Nephew, Stryker, Intersect ENT, Inc., SinuSys Corporation, InnAccel Technologies Pvt Ltd, TE Connectivity, Johnson & Johnson Services, Inc., Olympus Corporation.
Report Coverage | Details |
Sinus Dilation Devices Market Size in 2023 | USD 3.02 Billion |
Sinus Dilation Devices Market Size in 2024 | USD 3.31 Billion |
Sinus Dilation Devices Market Size by 2033 | USD 7.60 Billion |
Sinus Dilation Devices Market Growth Rate | CAGR of 9.67% from 2024 to 2033 |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | Product, Type, Procedure, Patient, End-use, and Regions |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Drivers
Rising incidences of sinus infection
The rising incidence of sinus infection can grow the sinus dilation devices market. The need for efficient treatment options grows as sinus infections become more prevalent. The patients and healthcare professionals searching for effective, less invasive alternatives to traditional surgeries are likely to increase their demand for sinus dilation devices, which offer a minimally invasive way to clear blocked sinus pathways.
Rising preference of patients for less invasive treatments
The rising preference of patients for less invasive treatments can boost the sinus dilation devices market. The patients are likely to favor less invasive procedures like balloon sinus dilation over being more aware of their options. This may increase the need for sinus dilation devices even more.
Restraint
Lack of awareness of sinus treatment
The lack of awareness of sinus treatment may slow down the sinus dilation devices market. The adoption of sinus dilation devices may be restricted if patients and healthcare professionals are not sufficiently educated about the advantages and accessibility of these devices.
Opportunity
Technical advancement in sinus treatment
Technical advancements in sinus treatment can be an opportunity to grow the sinus dilation devices market. The technical advancements in sinus treatment have significantly improved the accuracy, safety, and effectiveness of the procedure. The Technical advancements in sinus treatment include balloon sinuplasty, image-guided surgery, drug-eluting stents, advanced endoscopic tools, biologics and targeted therapies, cryotherapy, 3D printing, AI, and machine learning. The production of these technical advancements in sinus treatment can be an opportunity to boost the market.
The balloon sinus dilation devices segment dominated the sinus dilation devices market in 2023. In comparison of balloon sinus dilation (BSD) to standard sinus surgery, balloon sinus dilation devices are a less intrusive method. It includes clearing clogged nasal passages using a tiny, flexible balloon catheter, which minimizes tissue injury and expedites healing. There are fewer issues and a good safety profile linked to the operation. Because of this, it's a desirable choice for people and medical professionals who want to minimize the dangers involved with more intrusive surgical procedures.
The balloon sinus dilatation usually results in a faster recovery period for patients. For many patients, the less invasive nature of the surgery translates into a speedier return to regular activities and reduced postoperative discomfort. The demand for balloon sinus dilation devices has increased because of rising patient awareness and inclination for less intrusive therapies.
The functional endoscopic sinus surgery (FESS) instruments set segment is expected to grow at a notable rate in the sinus dilation devices market during the forecast period. There is a growing need for efficient surgical procedures like functional endoscopic sinus surgery (fess) instruments set due to the increased prevalence of chronic sinusitis and other sinus-related diseases.
The demand for functional endoscopic sinus surgery (fess) instruments and devices is rising as a result of the growing patient population. Technological developments in imaging methods and endoscopic devices are improving the efficacy and accuracy of functional endoscopic sinus surgery (fess) instruments. The improvements in surgical equipment, imaging tools, and high-definition cameras all lead to better surgical results and a rise in the use of functional endoscopic sinus surgery (fess) instruments.
The functional endoscopic sinus surgery (fess) instruments set is a less intrusive method of treating sinuses than open surgery. Less trauma, less blood, quicker recuperation periods, and fewer problems are all included. The demand for functional endoscopic sinus surgery (fess) instruments set instrument sets is being driven by patients and healthcare professionals' increased preference for less invasive procedures.
The sinuscopes segment dominated the sinus dilation devices market in 2023 and is expected to sustain this dominance throughout the forecast period. In the diagnosis and surgical treatment of sinus-related disorders, sinusoscopes are indispensable instruments. They offer a thorough visual representation of the sinus and nasal cavities, which is essential for precise diagnosis and efficient care.
The sinuscope performance has been greatly improved by advances in endoscopic technology, including high-definition imaging, stronger light sources, and more agility. With these enhancements, sinuscopes become more dependable and efficient, which leads to a rise in their use among medical professionals.
The need for sinus copes is being driven by the increased prevalence of nasal polyps, chronic sinusitis, and other sinus-related conditions. The growing number of patients are seeking treatment for these problems, which means that superior surgical and diagnostic instruments like sinuscopes are required. A rising number of people are choosing less invasive surgical treatments, which sinuscopes make possible.
The standalone segment dominated the sinus dilation devices market in 2023. The procedures for standalone sinus dilatation, including balloon sinus dilation, include less intrusive techniques. These procedures are very appealing to consumers and healthcare professionals since they don't involve any incisions or tissue or bone removal. The individuals who undertake independent sinus dilatation treatments usually recuperate faster than those who endure more invasive surgical procedures. The demand for solitary operations is fueled by the benefit of a speedier return to normal activities. The complication rates are often lower for stand-alone operations. Patients looking for a secure and efficient way to treat sinus problems are adopting these treatments at a higher rate because of their good safety profile.
The hybrid segment is expected to grow at the highest CAGR in the sinus dilation devices market during the forecast period. The benefits of both standard surgical techniques and solo sinus dilatation are combined in hybrid operations. With more therapy personalization and flexibility possible with this technique, individuals with various degrees of severity of sinus disease can achieve optimal results. Functional endoscopic sinus surgery (FESS) and balloon sinus dilatation methods can be used to create hybrid treatments that efficiently treat more complicated sinus problems. Better patient outcomes lead to increased acceptance among medical professionals.
A greater variety of sinus problems can be treated using hybrid treatments in a single surgical session. Because of their adaptability, they are a favored choice for patients who need extensive care that may not be entirely provided by solitary operations. The feasibility and efficiency of hybrid treatments have increased due to advancements in surgical technology and equipment.
The adult segment dominated the sinus dilation devices market in 2023. The adults experience higher rates of chronic sinusitis and other sinus-related illnesses than children do. These disorders are more common in adults because of things like allergies, extended exposure to environmental irritants, and the long-term impact of infections.
The adults are more prone to suffer from coexisting illnesses, including allergies, nasal polyps, and asthma, which can aggravate sinus problems. In the adult population, these comorbidities raise the need for sinus dilatation treatments. The sinus issues can arise and persist as a result of lifestyle variables that are more prevalent in adults, such as stress, smoking, and occupational exposure to pollutants. This highlights the necessity for efficient sinus treatment methods, such as dilation techniques.
The pediatric segment is expected to grow significantly in the sinus dilation devices market during the forecast period. Parents and medical professionals are becoming more knowledgeable about the frequency and consequences of pediatric sinusitis. As a result of greater knowledge, more people receive diagnoses and use sinus dilatation devices for therapy. The latest developments in technology have resulted in the creation of sinus dilation devices tailored for use in pediatric settings. Because these gadgets are designed with children's anatomical and physiological needs in mind, the operations are safer and more successful. When compared to standard surgical methods, minimally invasive techniques like balloon sinus dilation are especially appealing to pediatric patients since they produce less trauma, less discomfort, and faster recovery times. These less intrusive methods are preferred by parents and medical professionals for younger patients.
The hospitals segment dominated the sinus dilation devices market in 2023. Hospitals offer a comprehensive variety of medical treatments, including sophisticated diagnosis and treatment methods for sinus disorders. They do both independent and hybrid sinus dilation operations and are well-equipped to manage difficult cases. Usually, hospitals have access to the newest medical devices and technology. This includes sophisticated imaging technologies and cutting-edge sinus dilation tools, all of which are necessary for accurate and successful sinus treatments.
A wide range of medical specialists, such as surgeons, anesthesiologists, and ENT specialists, work at hospitals. From diagnosis to post-operative care, this interdisciplinary team can handle every facet of sinus therapy, guaranteeing excellent patient outcomes.
The ambulatory surgical centers segment is expected to grow at the highest rate in the sinus dilation devices market during the forecast period. Hospitals offer a comprehensive variety of medical treatments, including sophisticated diagnosis and treatment methods for sinus disorders. They do both independent and hybrid sinus dilation operations and are well-equipped to manage difficult cases.
Usually, hospitals have access to the newest medical devices and technology. This includes sophisticated imaging technologies and cutting-edge sinus dilation tools, all of which are necessary for accurate and successful sinus treatments. A wide range of medical specialists, such as surgeons, anesthesiologists, and ENT specialists, work at hospitals. From diagnosis to post-operative care, this interdisciplinary team can handle every facet of sinus therapy, guaranteeing excellent patient outcomes.
Segment Covered in the Report
By Product
By Type
By Procedure
By Patient
By End-use
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Sinus Dilation Devices Market
5.1. COVID-19 Landscape: Sinus Dilation Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Sinus Dilation Devices Market, By Product
8.1. Sinus Dilation Devices Market Revenue and Volume, by Product, 2024-2033
8.1.1. Balloon Sinus Dilation Devices
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Endoscopes
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Sinus Stents/Implants
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Functional Endoscopic Sinus Surgery (FESS) Instruments Set
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Sinus Dilation Devices Market, By Type
9.1. Sinus Dilation Devices Market Revenue and Volume, by Type, 2024-2033
9.1.1. Sinuscopes
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Rhinoscopes
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Sinus Dilation Devices Market, By Procedure
10.1. Sinus Dilation Devices Market Revenue and Volume, by Procedure, 2024-2033
10.1.1. Standalone
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Hybrid
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Sinus Dilation Devices Market, By Patient
11.1. Sinus Dilation Devices Market Revenue and Volume, by Patient, 2024-2033
11.1.1. Adult
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Pediatric
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global Sinus Dilation Devices Market, By End-use
12.1. Sinus Dilation Devices Market Revenue and Volume, by End-use, 2024-2033
12.1.1. Hospitals
12.1.1.1. Market Revenue and Volume Forecast (2021-2033)
12.1.2. Ambulatory Surgical Centers
12.1.2.1. Market Revenue and Volume Forecast (2021-2033)
12.1.3. Foundries
12.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 13. Global Sinus Dilation Devices Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.1.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.1.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.1.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.1.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.1.6.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.1.6.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.7.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.1.7.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.1.7.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.1.7.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.2.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.2.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.2.7. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.2.8. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.9.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.9.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.2.10. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.2.11. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.12.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.12.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.2.12.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.2.13. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.14.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.14.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.2.14.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.2.15. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.3.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.3.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.3.6.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.3.7. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.8.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.3.8.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.3.9. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.10.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.10.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.3.10.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.3.10.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.11.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.11.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.3.11.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.3.11.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.4.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.4.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.4.6.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.4.7. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.8.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.4.8.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.4.9. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.10.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.10.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.4.10.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.4.10.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.11.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.11.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.4.11.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.4.11.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.5.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.5.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.5.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.5.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.5.6.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.5.7. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.5.8.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.5.8.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.5.8.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
Chapter 14. Company Profiles
14.1. Smith+Nephew
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Stryker
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Intersect ENT, Inc
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Olympus Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. SinuSys Corporation
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Johnson & Johnson Services, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. TE Connectivity
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. InnAccel Technologies Pvt Ltd
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client